viral protein 30 inhibitors (Apath)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameviral protein 30 inhibitors (Apath)
Drug Alias NameVP30 inhibitors (Apath)viral replication inhibitors (Apath)AP-E009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman Immunodeficiency Virus tat Gene Products inhibitors
TargetsHuman Immunodeficiency Virus tat Gene Products
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApath LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApath LLC
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A